\-\ Texto\\:\\ \ \(0\)\
\-\ this\\ is\\ a\\ normal\\ finding\ \(0\)\
\-\ f\\-18\\ fdg\\ pet\\/ct\\ images\\ demonstrate\\ bilateral\\ symmetric\\ hypermetabolism\\ in\\ the\\ supraclavicular\\ region\\ which\\ on\\ ct\\ scan\\ correlates\\ with\\ low\\ attenuation\\ areas\\ consistent\\ with\\ fat\\.\ \(0\)\
\-\ supraclavicular\\ brown\\ fat\ \(1\)\
\-\ supraclavicular\\ lymph\\ node\\ metastasis\ \(0\)\
\-\ benign\\ uptake\\ in\\ muscle\\ due\\ to\\ tension\ \(0\)\
\-\ benign\\ supraclavicular\\ brown\\ fat\\ metabolism\ \(0\)\
\-\ 55\\ year\\ old\\ female\\ patient\\ with\\ a\\ diagnosis\\ of\\ hepatocellular\\ carcinoma\\.\\ f\\-18\\ fdg\\ pet\\/ct\\ scan\\ for\\ staging\\/evaluation\\.\ \(0\)\
\-\ the\\ ability\\ to\\ recognize\\ brown\\ fat\\ hypermetabolism\\ is\\ critical\\ in\\ evaluating\\ pet\\ scans\\.\\ this\\ is\\ a\\ normal\\ finding\\ and\\ should\\ not\\ be\\ confused\\ with\\ metastatic\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ supraclavicular\\:\\ 0\\.45338753693832085\ \(0\)\
\-\ brown\\:\\ 0\\.34315935025451283\ \(0\)\
\-\ hypermetabolism\\:\\ 0\\.30661759708837016\ \(0\)\
\-\ pet\\:\\ 0\\.2882565844875093\ \(0\)\
\-\ fat\\:\\ 0\\.2581502259366267\ \(0\)\
\-\ fdg\\:\\ 0\\.22472707859535548\ \(0\)\
\-\ finding\\:\\ 0\\.13638983143203465\ \(0\)\
\-\ recognize\\:\\ 0\\.1249701196714791\ \(0\)\
\-\ scan\\:\\ 0\\.12310488090495532\ \(0\)\
\-\ correlates\\:\\ 0\\.11857908782738047\ \(0\)\
\-\ metabolism\\:\\ 0\\.11857908782738047\ \(0\)\
\-\ ct\\:\\ 0\\.11849332797391084\ \(0\)\
\-\ tension\\:\\ 0\\.11727943142231256\ \(0\)\
\-\ critical\\:\\ 0\\.1143864500848376\ \(0\)\
\-\ ability\\:\\ 0\\.11236353929767774\ \(0\)\
\-\ confused\\:\\ 0\\.10969719579616428\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.10665890781903258\ \(0\)\
\-\ evaluating\\:\\ 0\\.10436194687962386\ \(0\)\
\-\ scans\\:\\ 0\\.09027589667517832\ \(0\)\
\-\ node\\:\\ 0\\.08917328933723488\ \(0\)\
\-\ 55\\:\\ 0\\.08917328933723488\ \(0\)\
\-\ symmetric\\:\\ 0\\.0889077743882812\ \(0\)\
\-\ is\\:\\ 0\\.08523615089228634\ \(0\)\
\-\ normal\\:\\ 0\\.08471909318811892\ \(0\)\
\-\ with\\:\\ 0\\.08126049487351689\ \(0\)\
\-\ lymph\\:\\ 0\\.0806753398545995\ \(0\)\
\-\ uptake\\:\\ 0\\.07977600176907394\ \(0\)\
\-\ attenuation\\:\\ 0\\.0793814645846686\ \(0\)\
\-\ in\\:\\ 0\\.07742728514394655\ \(0\)\
\-\ metastasis\\:\\ 0\\.07603949955729271\ \(0\)\
\-\ muscle\\:\\ 0\\.07366782867429178\ \(0\)\
\-\ this\\:\\ 0\\.07129925095864031\ \(0\)\
\-\ areas\\:\\ 0\\.0704375869260373\ \(0\)\
\-\ should\\:\\ 0\\.06769545775803927\ \(0\)\
\-\ region\\:\\ 0\\.062057267419778836\ \(0\)\
\-\ carcinoma\\:\\ 0\\.062057267419778836\ \(0\)\
\-\ due\\:\\ 0\\.0596362012378962\ \(0\)\
\-\ low\\:\\ 0\\.05953107117067856\ \(0\)\
\-\ metastatic\\:\\ 0\\.0569004992357767\ \(0\)\
\-\ consistent\\:\\ 0\\.05625445938838516\ \(0\)\
\-\ bilateral\\:\\ 0\\.05575791653338923\ \(0\)\
\-\ demonstrate\\:\\ 0\\.05393562538441843\ \(0\)\
\-\ diagnosis\\:\\ 0\\.05378214387452885\ \(0\)\
\-\ to\\:\\ 0\\.05187351141169901\ \(0\)\
\-\ female\\:\\ 0\\.050063116995331926\ \(0\)\
\-\ images\\:\\ 0\\.04799028224791211\ \(0\)\
\-\ which\\:\\ 0\\.04717517417704512\ \(0\)\
\-\ disease\\:\\ 0\\.04354965671831526\ \(0\)\
\-\ be\\:\\ 0\\.04208635026025638\ \(0\)\
\-\ the\\:\\ 0\\.04140290589567951\ \(0\)\
\-\ not\\:\\ 0\\.04095717853665425\ \(0\)\
\-\ patient\\:\\ 0\\.03374396343920828\ \(0\)\
\-\ year\\:\\ 0\\.03197304104848495\ \(0\)\
\-\ for\\:\\ 0\\.03144517346368132\ \(0\)\
\-\ on\\:\\ 0\\.031333627876451005\ \(0\)\
\-\ old\\:\\ 0\\.03070518714936796\ \(0\)\
\-\ and\\:\\ 0\\.021438220540753356\ \(0\)\
\-\ of\\:\\ 0\\.02030299268508782\ \(0\)\
